Denna webbsida är endast avsedd för läkare och sjukvårdspersonal med förskrivningsrätt.

Systemic treatment for advanced hepatocellular carcinoma – Live streaming from the UK with Prof. Jeff Evans

MSD and Eisai are pleased to invite you for a live webcast with a renown scientific leader in the field of hepatocellular carcinoma, prof. Jeff Evans. 

Date: Tuesday, 03 November 2020
Time: 12:00 – 13.00 (Swedish time)

Attendance to this event is possible in two ways:

  1. At your office/home, via the webcast link


  1. Together with your colleagues if your hospital is having a streaming site. Please still register via the link so we can order lunch for you. If you’re interested in having a streaming site at your hospital please contact [email protected] and/or [email protected]

About the speaker:
Prof. Jeff Evans is the Director of the Institute of Cancer Sciences at the University of Glasgow and a Professor of Translational Cancer Research. He is also the Lead of the Glasgow Experimental Cancer Medicine Centre and the Head of the Experimental Cancer Therapeutics Unit. Prof. Evans holds the title as Honorary Group Leader at the CRUK Beatson Institute. Furthermore, he is the co-editor of the clinical research section of the British Journal of Cancer and has been an experienced investigator in key studies involving hepatocellular carcinoma.

MSD and Eisai covers the cost of the lunch at the dedicated streaming sites in the presence of a MSD or an Eisai representative.

More info

Liknande poster

EU-kommissionen godkänner Keytruda för neoadjuvant/adjuvant behandling av trippelnegativ bröstcancer

Nyheter inom behandling av metastaserad lungcancer- kan det bli en kronisk sjukdom?

NT-rådet rekommenderar Keytruda som adjuvant behandling för njurcellscancer